Literature DB >> 2743261

Histologic and mammographic specificity of risk factors for benign breast disease.

R A Bright1, A S Morrison, J Brisson, N A Burstein, N L Sadowsky, D B Kopans, J E Meyer.   

Abstract

This study evaluates the effects of potential risk factors for benign breast disease (BBD) with special attention to the histologic and mammographic specificity of the effects. Cases were 172 women with BBD that underwent biopsy; controls were 134 women free of breast signs or symptoms. All cases and controls had undergone mammography. For all types of BBD combined, parity, use of oral contraceptives, and use of exogenous estrogen after menopause were strongly protective, whereas obesity and early menarche were weakly protective. Family history of breast cancer was virtually unrelated to BBD. The protective effect of parity was stronger for BBD with intralobular or extralobular fibrosis, and with mammographic homogeneous density or large nodular densities, than it was for BBD without these characteristics. Similar relations with the histologic and mammographic features were observed for obesity. These findings suggest that some risk factors for BBD have effects that are related to specific features of its morphology.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2743261     DOI: 10.1002/1097-0142(19890801)64:3<653::aid-cncr2820640315>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Hyperplasia and breast cancer.

Authors:  R A Bright
Journal:  Cancer Causes Control       Date:  1993-05       Impact factor: 2.506

2.  Risk factors for benign breast disease according to histopathological type: comparisons with risk factors for breast cancer.

Authors:  Y Minami; N Ohuchi; Y Taeda; A Fukao; S Hisamichi
Journal:  Jpn J Cancer Res       Date:  1998-02

3.  Benign breast disease and changes in mammographic breast density.

Authors:  Laura L Reimers; Mandy Goldberg; Parisa Tehranifar; Karin B Michels; Barbara A Cohn; Julie D Flom; Ying Wei; Piera Cirillo; Mary Beth Terry
Journal:  Breast Cancer Res       Date:  2021-04-26       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.